21.12
0.14%
-0.03
시간 외 거래:
21.12
Catalyst Pharmaceuticals Inc (CPRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
10.91%
98.51
|
110.57 | 102.69 | 99.58 | 85.37 |
Cost Of Revenue |
20.80%
12.52
|
15.81 | 14.17 | 12.04 | 9.946 |
Gross Profit |
9.26%
85.99
|
94.76 | 88.52 | 87.54 | 75.42 |
Operating Expenses
|
10.92%
58.86
|
53.07 | 125.71 | 40.84 | 39.81 |
Benefits Costs and Expenses |
8.70%
69.42
|
63.86 | 140.71 | 51.07 | 48.05 |
Costs And Expenses |
8.70%
69.42
|
63.86 | 140.71 | 51.07 | 48.05 |
Operating Income/Loss |
34.94%
27.13
|
41.69 | -37.19 | 46.70 | 35.61 |
Income/Loss From Continuing Operations Before Tax |
37.72%
29.09
|
46.71 | -38.02 | 48.51 | 37.31 |
Income Tax Expense/Benefit |
50.99%
5.814
|
11.86 | -7.257 | 10.75 | 7.745 |
Income/Loss From Continuing Operations After Tax |
33.20%
23.27
|
34.84 | -30.76 | 37.76 | 29.57 |
Net Income/Loss
|
33.20%
23.27
|
34.84 | -30.76 | 37.76 | 29.57 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
79,545%
116.81
|
0.1467 | 106.57 | 106.26 | 105.56 |
Diluted Average Shares |
6.92M%
123.40
|
0.00178 | 106.57 | 113.67 | 113.99 |
Basic Earnings Per Share |
39.39%
0.20
|
0.33 | -0.29 | 0.36 | 0.28 |
Diluted Earnings Per Share |
38.71%
0.19
|
0.31 | -0.29 | 0.33 | 0.26 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):